Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,572,000 | 4,807,000 | 3,750,000 | 3,843,000 | 2,470,000 |
| Depreciation Amortization | 1,154,000 | 1,133,000 | 1,132,000 | 891,000 | 912,000 |
| Income taxes - deferred | -540,000 | 81,000 | 91,000 | -1,272,000 | 127,000 |
| Accounts receivable | -256,000 | -1,053,000 | -695,000 | -22,000 | -1,381,000 |
| Accounts payable and accrued liabilities | 3,528,000 | 1,826,000 | -1,059,000 | 732,000 | 322,000 |
| Other Working Capital | 5,254,000 | -94,000 | -1,578,000 | 368,000 | -510,000 |
| Other Operating Activity | -3,024,000 | -639,000 | 2,186,000 | -355,000 | 1,330,000 |
| Operating Cash Flow | $10,688,000 | $6,061,000 | $3,827,000 | $4,185,000 | $3,270,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -849,000 | 254,000 | -149,000 | 625,000 | 222,000 |
| PPE Investments | -1,021,000 | -1,077,000 | -1,208,000 | -791,000 | -584,000 |
| Net Acquisitions | -1,976,000 | N/A | -1,760,000 | -2,080,000 | 8,636,000 |
| Purchase Of Investment | -19,492,000 | -22,954,000 | -9,671,000 | -16,375,000 | -12,067,000 |
| Sale Of Investment | 16,059,000 | 21,035,000 | 11,600,000 | 13,462,000 | 3,317,000 |
| Other Investing Activity | -45,000 | -50,000 | -71,000 | 77,000 | -38,000 |
| Investing Cash Flow | $-7,324,000 | $-2,792,000 | $-1,259,000 | $-5,082,000 | $-514,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,305,000 | 7,336,000 | 9,270,000 | 5,281,000 | 2,691,000 |
| Debt Issued | 2,334,000 | 2,176,000 | 835,000 | 5,633,000 | -53,000 |
| Debt Repayment | -1,932,000 | -9,158,000 | -1,791,000 | -2,815,000 | N/A |
| Common Stock Issued | 176,000 | 187,000 | 1,423,000 | 226,000 | 120,000 |
| Common Stock Repurchased | -2,700,000 | -1,701,000 | -1,685,000 | -1,998,000 | N/A |
| Dividend Paid | -954,000 | -818,000 | -776,000 | -705,000 | -684,000 |
| Other Financing Activity | -1,796,000 | -288,000 | -9,517,000 | -5,195,000 | -2,873,000 |
| Financing Cash Flow | $-2,567,000 | $-2,266,000 | $-2,241,000 | $427,000 | $-799,000 |
| Exchange Rate Effect | 7,000 | 0 | -2,000 | 4,000 | 5,000 |
| Beginning Cash Position | 4,937,000 | 3,934,000 | 3,609,000 | 4,075,000 | 2,113,000 |
| End Cash Position | 5,741,000 | 4,937,000 | 3,934,000 | 3,609,000 | 4,075,000 |
| Net Cash Flow | $804,000 | $1,003,000 | $325,000 | $-466,000 | $1,962,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,688,000 | 6,061,000 | 3,827,000 | 4,185,000 | 3,270,000 |
| Capital Expenditure | -1,021,000 | -1,077,000 | -1,208,000 | -791,000 | -584,000 |
| Free Cash Flow | 9,667,000 | 4,984,000 | 2,619,000 | 3,394,000 | 2,686,000 |